<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000537170"><TermName>epothilone ZK219477</TermName><TermPronunciation>(eh-POTH-ih-lone ...)</TermPronunciation><TermDefinition><DefinitionText>A form of the substance epothilone that is made in the laboratory. It is being studied in the treatment of some types of cancer. Epothilone ZK2219477 stops the growth of tumor cells by blocking cell division. It is a type of antimitotic agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718216" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epothilone ZK219477&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718215" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;epotilona ZK219477&quot;" language="es" id="_4"/><SpanishTermName>epotilona ZK219477</SpanishTermName><SpanishTermDefinition><DefinitionText>Forma de la sustancia química epotilona que se produce en el laboratorio. Está en estudio para el tratamiento de algunos tipos de cáncer. La epotilona ZK219477 detiene el crecimiento de las células tumorales porque bloquea la multiplicación celular. Es un tipo de antimitótico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-07-06</DateFirstPublished></GlossaryTerm>
